|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 January 2001, Vol. 97, No. 1, pp. 162-168
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Ristocetin-dependent, but not botrocetin-dependent, binding of
von Willebrand factor to the platelet glycoprotein Ib-IX-V complex
correlates with shear-dependent interactions
Jing-Fei Dong,
Michael C. Berndt,
Alicia Schade,
Larry V. McIntire,
Robert K. Andrews, and
José A. López
From the Departments of Medicine and Molecular and
Human Genetics, Baylor College of Medicine, and the Cox Laboratory for
Biomedical Engineering, Rice University, Houston, TX; and the Hazel and
Pip Appel Vascular Biology Laboratory, Baker Medical Research
Institute, Melbourne, Australia.
Under conditions of high shear stress, both hemostasis and
thrombosis are initiated by the interaction of the platelet membrane glycoprotein (GP) Ib-IX-V complex with its adhesive ligand, von Willebrand factor (vWF), in the subendothelial matrix or plasma. This
interaction involves the A1 domain of vWF and the N-terminal extracellular region of GP Ib (His-1-Glu-282), and it can also be
induced under static conditions by the modulators ristocetin and
botrocetin. In this study, a panel of anti-vWF and anti-GP Ib
antibodies previously characterized for their effects on ristocetin- and botrocetin-dependent vWF-GP Ib-IX-V interactions was analyzed for
their capacity to inhibit either the adhesion of Chinese hamster ovary
cells expressing recombinant GP Ib to surface-associated vWF under
hydrodynamic flow or shear-stress-induced platelet aggregation. The
combined results suggest that the shear-dependent interactions between
vWF and GP Ib closely correlate with ristocetin- rather than
botrocetin-dependent binding under static conditions and that certain
anti-vWF monoclonal antibodies are able to selectively inhibit
shear-dependent platelet aggregation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Berny, T. C. White, E. I. Tucker, L. A. Bush-Pelc, E. Di Cera, A. Gruber, and O. J.T. McCarty
Thrombin Mutant W215A/E217A Acts as a Platelet GPIb Antagonist
Arterioscler Thromb Vasc Biol,
February 1, 2008;
28(2):
329 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Choi, K. Aboulfatova, H. J. Pownall, R. Cook, and J.-f. Dong
Shear-induced Disulfide Bond Formation Regulates Adhesion Activity of von Willebrand Factor
J. Biol. Chem.,
December 7, 2007;
282(49):
35604 - 35611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ulrichts, M. Udvardy, P. J. Lenting, I. Pareyn, N. Vandeputte, K. Vanhoorelbeke, and H. Deckmyn
Shielding of the A1 Domain by the D'D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V
J. Biol. Chem.,
February 24, 2006;
281(8):
4699 - 4707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lasser, P. Guchhait, J. L. Ellsworth, P. Sheppard, K. Lewis, P. Bishop, M. A. Cruz, J. A. Lopez, and J. Fruebis
C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen
Blood,
January 15, 2006;
107(2):
423 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Peng, C. N. Shrimpton, J.-f. Dong, and J. A. Lopez
Gain of von Willebrand factor-binding function by mutagenesis of a species-conserved residue within the leucine-rich repeat region of platelet glycoprotein Ib{alpha}
Blood,
September 15, 2005;
106(6):
1982 - 1987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Peng, M. C. Berndt, M. A. Cruz, and J. A. Lopez
The {alpha}1 helix-{beta}13 strand spanning Leu214 to Val229 of platelet glycoprotein Ib{alpha} facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1
Blood,
December 15, 2004;
104(13):
3971 - 3978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Padilla, J. L. Moake, A. Bernardo, C. Ball, Y. Wang, M. Arya, L. Nolasco, N. Turner, M. C. Berndt, B. Anvari, et al.
P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface
Blood,
March 15, 2004;
103(6):
2150 - 2156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kanaji, T. Kanaji, K. Furihata, K. Kato, J. L. Ware, and T. J. Kunicki
Convulxin Binds to Native, Human Glycoprotein Ib{alpha}
J. Biol. Chem.,
October 10, 2003;
278(41):
39452 - 39460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-f. Dong, J. L. Moake, A. Bernardo, K. Fujikawa, C. Ball, L. Nolasco, J. A. Lopez, and M. A. Cruz
ADAMTS-13 Metalloprotease Interacts with the Endothelial Cell-derived Ultra-large von Willebrand Factor
J. Biol. Chem.,
August 8, 2003;
278(32):
29633 - 29639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ulrichts, K. Vanhoorelbeke, S. Cauwenberghs, S. Vauterin, H. Kroll, S. Santoso, and H. Deckmyn
Von Willebrand Factor But Not {alpha}-Thrombin Binding to Platelet Glycoprotein Ib{alpha} Is Influenced by the HPA-2 Polymorphism
Arterioscler Thromb Vasc Biol,
July 1, 2003;
23(7):
1302 - 1307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-f. Dong, J. L. Moake, L. Nolasco, A. Bernardo, W. Arceneaux, C. N. Shrimpton, A. J. Schade, L. V. McIntire, K. Fujikawa, and J. A. Lopez
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions
Blood,
December 1, 2002;
100(12):
4033 - 4039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. M. Molenaar, C. C. M. Appeldoorn, S. A. M. de Haas, I. N. Michon, A. Bonnefoy, M. F. Hoylaerts, H. Pannekoek, T. J. C. van Berkel, J. Kuiper, and E. A. L. Biessen
Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists
Blood,
November 15, 2002;
100(10):
3570 - 3577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shen, J.-f. Dong, G. M. Romo, W. Arceneaux, A. Aprico, E. E. Gardiner, J. A. Lopez, M. C. Berndt, and R. K. Andrews
Functional analysis of the C-terminal flanking sequence of platelet glycoprotein Ibalpha using canine-human chimeras
Blood,
January 1, 2002;
99(1):
145 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Cauwenberghs, K. Vanhoorelbeke, S. Vauterin, D. F. Westra, G. Romo, E. G. Huizinga, J. A. Lopez, M. C. Berndt, J. Harsfalvi, and H. Deckmyn
Epitope mapping of inhibitory antibodies against platelet glycoprotein Ib{alpha} reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ib{alpha}
Blood,
August 1, 2001;
98(3):
652 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-f. Dong, P. Ye, A. J. Schade, S. Gao, G. M. Romo, N. T. Turner, L. V. McIntire, and J. A. Lopez
Tyrosine Sulfation of Glycoprotein Ibalpha . ROLE OF ELECTROSTATIC INTERACTIONS IN VON WILLEBRAND FACTOR BINDING
J. Biol. Chem.,
May 11, 2001;
276(20):
16690 - 16694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Baglia, K. O. Badellino, C. Q. Li, J. A. Lopez, and P. N. Walsh
Factor XI Binding to the Platelet Glycoprotein Ib-IX-V Complex Promotes Factor XI Activation by Thrombin
J. Biol. Chem.,
January 11, 2002;
277(3):
1662 - 1668.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|